Intervention Group:Apatinib Mesylate Tablets 500 mg qd p.o.

2 trials

Sponsors

Fourth Hospital, Hebei Medical University

Conditions

Gastric Cancer

Phase 4

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Active, not recruitingChiCTR-IPR-15006994

Fourth Hospital, Hebei Medical UniversityGastric Cancer

Start: 2015-09-15Updated: 2017-04-18

Apatinib as Maintenance Therapy After First-line Chemotherapy (DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

Active, not recruitingChiCTR-IPR-15006993

Fourth Hospital, Hebei Medical UniversityGastric Cancer

Start: 2015-09-15Updated: 2017-04-18